-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Evidence-based therapy for the ANCA associated vasculitides: what do the trials show so far?
Lovesh Dyall , Dimitrios Chanouzas & Matthew David Morgan
Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trial design in advanced head and neck cancer: from past experiences to future perspectives
Gilberto de Castro Jr, Carlos Henrique dos Anjos, Yassine Lalami,Ahmad Awada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Optimism and oncology trials: help or hindrance?
Blair Henry, Michael Szego
Editorial: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation